Ascendis Pharma Reports Third Quarter 2024 Financial Results
YORVIPATH launching in U.S. with product availability expected mid-January 2025; ex-U.S. YORVIPATH revenue of €8.5 million in Q3– TransCon CNP ...
uk.investing.com on MSN12h
Denmark shares lower at close of trade; OMX Copenhagen 20 down 0.14%
Denmark equities were lower at the close on Thursday, as losses in the Real Estate, Personal&Household Goods and Healthcare ...
Denmark stocks lower at close of trade; OMX Copenhagen 20 down 0.14%
Denmark stocks were lower after the close on Thursday, as losses in the Real Estate, Personal & Household Goods and ...
Noble Corporation plc announces submission of request for removal from trading and official listing on Nasdaq Copenhagen
Noble Corporation plc ("Noble", the "Company") (NYSE: NE, CSE: NOBLE) announces that today, Noble has submitted a request for the ...
BioPorto A/S: BioPorto Announces Interim Results and Business Update for the Third Quarter and Nine Months of Fiscal 2024
November 14, 2024Announcement no. 22 BioPorto Announces Interim Results and Business Update for the Third Quarter and Nine Months of Fiscal 2024 Revenue growth and strategic execution COPENHAGEN, Denm ...